ICD-10-PCS 2027 procedure code
XY0YX37Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7
Short description: Extracorporeal Introduction of Nafamostat, New Tech 7
Code last changed in FY2022 (effective October 1, 2021). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data
About XY0YX37
XY0YX37 is the ICD-10-PCS code for a introduction procedure on the extracorporeal using an external approach with nafamostat anticoagulant (qualifier: new technology group 7). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.
It was added in FY2022, effective October 1, 2021.
What each character means
- 1. Section
- XNew Technology
- 2. Body System
- YExtracorporeal
- 3. Operation
- 0Introduction
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
- 4. Body Part
- YExtracorporeal
- 5. Approach
- XExternal
Procedures performed directly on the skin or mucous membrane and procedures performed indirectly by the application of external force through the skin or mucous membrane
- 6. Device / Substance / Technology
- 3Nafamostat Anticoagulant
Includes: LTX Regional Anticoagulant; Niyad(tm)
- 7. Qualifier
- 7New Technology Group 7
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2022 (effective 10/1/2021): Added
- No changes since FY2022.
Common questions about XY0YX37
Is XY0YX37 a valid ICD-10-PCS code for 2027?
- Yes. XY0YX37 is valid for inpatient procedures from October 1, 2026 through September 30, 2027.